Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Widodo Makmur Perkasa Tbk. (WMPP) Price & Performance

UBC Medical Indonesia Tbk.Trade
Widodo Makmur Perkasa Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Widodo Makmur Perkasa Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Widodo Makmur Perkasa Tbk. trades at Rp19 (market cap 588.38B, 35.13M 24h volume). The key difference: UBC Medical Indonesia Tbk. and Widodo Makmur Perkasa Tbk. are close in size by market cap, and Widodo Makmur Perkasa Tbk. is more actively traded (35.13M versus 3.48M). Which is the better fit depends on your goals.

LABSWMPP
Market Cap
576.7B588.38B
Volume
3.48M35.13M
Lot
34.82K351.26K
Turnover
522.79M670.08M
Average Price
150.1319.08
Value
522.79M670.08M
Indicative Equilibrium Price
14819
Indicative Equilibrium Volume
35060.5K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
WMPP
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Widodo Makmur Perkasa Tbk.

PT Widodo Makmur Perkasa Tbk (the Company) was established based on Notarial Deed No. 1 dated April 1, 2003 of Notary Durachman, S.H. The ultimate controlling shareholder of the Company is Mr. Tumiyana. The company commenced commercial operations in April 1, 2003

Read more on WMPP